Download PDF
Thromb Haemost 1989; 61(01): 150-151
DOI: 10.1055/s-0038-1646547
Letter to the Editor
Schattauer GmbH Stuttgart

Elevated Fibronectin Plasma Levels in Diabetes Mellitus Are Expression of Increased Synthesis and Release by Vascular Endothelium

R Musso
1   The Chair of Hematology, University of Catania, Catania, Italy
,
A Longo
1   The Chair of Hematology, University of Catania, Catania, Italy
,
R R Cacciola
2   The Chair of Gerontology and Geriatrics, University of Catania, Catania, Italy
,
A Lombardo
2   The Chair of Gerontology and Geriatrics, University of Catania, Catania, Italy
,
R Giustolisi
1   The Chair of Hematology, University of Catania, Catania, Italy
,
E Cacciola
1   The Chair of Hematology, University of Catania, Catania, Italy
› Author Affiliations
Further Information

Publication History

Received 01 June 1988

Accepted after revision 22 September 1988

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Jaffe EA, Mosher DF. Synthesis of fibronectin by cultured human endothelial cells. J Exp Med 1978; 1779-1783
    PubMedGoogle Scholar
  • 2 Bastida E, Escolar G, Ordinas A, Sixma JJ. Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood 1987; 70: 1437-1442
    PubMedGoogle Scholar
  • 3 Giustolisi R, Lombardo T, Musso R, Cacciola E. Factor VIII antigen plasma levels in diabetes mellitus. Enhanced endothelial release and storage Thromb Haemostas 1980; 44: 46
    PubMedGoogle Scholar
  • 4 Musso R, Longo A, Cacciola RR, Lombardo A, Giustolisi R. Plasma fibronectin in diabetes mellitus (DM) type II. Possible evidence for a high endothelium storage. Reunion del Grupo de Estudio sobre la Hemostasia y la Thrombosis (GEHT) Pamplona 02.05.1986 (Abstr)
    PubMedGoogle Scholar
  • 5 Solerte SB, Fioravanti M, Ferrari E. Plasma fibronectin as an indicator of microvascular damage in diabetic patients. Rapid and sensitive evaluation by a radial immunodiffusion technique Ric Clin Lab 1987; 17: 251-258
    PubMedGoogle Scholar
  • 6 Robertson B, Pandolfi M, Nilsson IM. “Fibrinolytic capacity” in healthy volunteers as estimated from effect of venous occlusion of arms. Acta Chir Scand 1972; 138: 429-436
    PubMedGoogle Scholar
  • 7 Giustolisi R, Musso R, Russo M, Catania N, Lombardo T, Cacciola E. Possible evidence for an increased factor VIII antigen synthesis in vascular endothelium of diabetic subjects. Thromb Haemostas 1982; 47: 293
    PubMedGoogle Scholar
  • 8 Schwarz HP, Luger A, Graf H, Stummvoll HK, Aiginger P. Fibronectin and venostasis. Thromb Haemostas 1982; 48: 345
    PubMedGoogle Scholar
  • 9 Cierniewski CS, Wilczynska M, Augustyniak W, Kowalska MA. Elevated plasma fibronectin during venous occlusion. Thromb Haemostas 1985; 53: 157
    PubMedGoogle Scholar
  • 10 National Diabetes Data Group: classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 28: 1039
    CrossrefPubMed
  • 11 Bykowska K, Wegrzynowicz Z, Lopaciuk S, Kopeć M. Effect of proteolysis on quantitation of plasma fibronectin concentration by two immunoassays (electroimmunoassay and immunoturbidimetric technique). Thromb Haemostas 1985; 53: 377-380
    PubMedGoogle Scholar